Selank and GABAergic Modulation: Evidence in Anxiolysis, Stress Homeostasis, and Immunoneural Regulation (2025)

Abstract

Selank is a heptapeptide derived from the immunoregulatory factor Tuftsin, developed as a non-sedative anxiolytic agent. Studies published between 1990 and 2024 show that Selank modulates GABAergic pathways, reduces hyperactivity of the HPA axis, alters cytokine expression and improves emotional stability and cognitive performance under stress. This review consolidates pre-clinical evidence and small-scale human trials.

1. introduction

Selank was conceived at the Russian Research Institute of Biotechnology as:

• peptide anxiolytic,
• immunoneural modulator,
• behavioural stabilisation agent,
• non-sedative alternative to benzodiazepines.

It is structurally based on the sequence Thr-Lys-Pro-Arg-Pro-Gly-Proderived from the immune factor Tuftsina natural phagocytic modulator.

The objective of the development was to create a compound that:

• reduced anxiety without sedation,
• stabilise the response to stress,
• modulate the GABA pathway indirectly,
• acts as a neuroimmune regulator.

2. Fundamental Biological Mechanisms

2.1 Modulation of the GABA system (main anxiolytic pathway)

Selank increases the sensitivity and functional availability of:

• GABA-AThe main inhibitory receptors in the CNS.

Observed effects:

• Reduced neuronal excitability
• Decrease in the "neural noise" associated with anxiety
• Emotional stabilisation
• Relaxation without sedation

Compared to benzodiazepines:

• Does not cause rapid tolerance
• Not addictive
• Does not impair motor coordination

2.2 Regulation of the HPA (Hypothalamic-Pituitary-Adrenal) axis

Selank has demonstrated:

• Reduction of CRH (Corticotropin Releasing Hormone)
• Stress-induced ACTH reduction
• Normalisation of cortisol production

These effects explain their ability to reduce:

• anticipatory anxiety,
• exaggerated response to stress,
• psychosomatic tension.

2.3 Modulation of cytokines and the immunoneural pathway

As a derivative of Tuftsin, Selank plays an immunological role.

Studies show:

• ↓ IL-6
• ↓ TNF-α
• ↓ Mild systemic inflammation
• ↑ IFN-γ in states of low immunity

This mechanism contributes to:

• emotional stability,
• reduction of mental fatigue,
• neuroinflammatory modulation.

2.4 Improving cognitive function under stress

Simultaneously anxiolytic and pro-cognitive, Selank:

• improves working memory
• accelerates processing speed
• increases mental stamina in stressful environments
• reduces anxiety-induced distraction

Unlike Semax:

• does not stimulate BDNF as much
• does not increase performance in already calm volunteers
• acts more on emotional stability than on neural plasticity

It is therefore ideal in cognitive stress, examinations, work overload, etc.

3. Pre-clinical and clinical evidence

3.1 Studies with induced anxiety

Consistent results show:

• reduction of anxious behaviour
• normalisation of physiological markers
• no sedation

3.2 Human trials (Russia and Ukraine)

In small-scale clinical trials:

• reduction of generalised anxiety symptoms
• improved focus and decision-making
• quick effects (30-60 min)
• excellent tolerability

In contrast to benzodiazepines:

• no negative impact on memory
• no motor dysfunction
• no increase in daytime sleepiness

3.3 Effects on mild depression

In some models, Selank has shown:

• normalisation of monoamine
• moderate increase in serotonin in the cortex
• potential future application in mild depressive states

There is still not enough clinical strength for definitive conclusions.

4. Bioavailability and Pharmacodynamics

• Typical experimental administration: intranasal
• Rapid absorption through the cribiform lamina
• Central action in ~10 minutes
• Short half-life: 15-20 minutes
• Prolonged effects due to downstream neurochemical modulation

Like Semax, the effect lasts much longer than the plasma half-life.

5. Research applications

5.1 Anxiety and stress

The most solid area, with improvements recorded in:

• generalised anxiety
• situational anxiety
• cognitive stress
• mild post-traumatic stress

5.2 Neuroinflammation and immunomodulation

Results include:

• reduction of inflammatory cytokines
• stabilisation of microglia
• improving mental fatigue associated with inflammation

5.3 Emotionally charged cognition

When anxiety interferes with performance:

• faster decisions
• less distraction
• greater mental coherence

6. Safety, Side Effects and Contraindications

High safety profile

Observed effects:

• mild nasal irritation
• mild sedation in extremely sensitive individuals
• drowsiness if used in high doses
• occasional headache

Theoretical contraindications

• severe depression (risk of undertreatment)
• psychosis or mania
• epilepsy (rarely increases paradoxical excitability)
• pregnancy / lactation
• active autoimmune diseases (insufficient data)

7. Conclusion

Selank is a neuromodulation peptide aimed at:

• reducing anxiety,
• emotional stability,
• regulation of the stress response,
• immunoneural modulation.

Research shows a unique profile: anxiolytic without sedation, immunomodulatory without suppression and cognitively neutral to slightly positive. It is one of the most promising candidates for research at the interface between neuroscience and immunology.